Your browser doesn't support javascript.
loading
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.
Niessner, Heike; Hüsch, Anna; Kosnopfel, Corinna; Meinhardt, Matthias; Westphal, Dana; Meier, Friedegund; Schilling, Bastian; Sinnberg, Tobias.
Afiliación
  • Niessner H; Division of Dermatooncology, Department of Dermatology, University of Tuebingen, Liebermeisterstr. 25, 72076 Tuebingen, Germany.
  • Hüsch A; Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", 72076 Tuebingen, Germany.
  • Kosnopfel C; Division of Dermatooncology, Department of Dermatology, University of Tuebingen, Liebermeisterstr. 25, 72076 Tuebingen, Germany.
  • Meinhardt M; Department of Hematology, Oncology and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
  • Westphal D; Department of Pathology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
  • Meier F; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.
  • Schilling B; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.
  • Sinnberg T; Department of Dermatology, Carl Gustav Carus Medical Center, TU Dresden, 01307 Dresden, Germany.
Cancers (Basel) ; 15(23)2023 Nov 22.
Article en En | MEDLINE | ID: mdl-38067230
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania